搜索筛选:
搜索耗时1.2781秒,为你在为你在102,285,761篇论文里面共找到 66 篇相符的论文内容
类      型:
[会议论文] 作者:Xin Zheng,Kairui Feng,Pei Hu,Jun Shi,Ji Jiang, 来源:第四届定量药理学与新药评价国际会议·2013(The 4th International Symposium in Qu 年份:2013
Background:Concentration dependent Blood to plasma ratio (B/P) of zonisamide(ZNS) was observed in clinical trial, which requires measuring both plasma concentration and whole blood concentration for c...
[会议论文] 作者:Rui Chen,Dongyang Liu,Jun Shi,Ji Jiang,Pei Hu, 来源:第四届定量药理学与新药评价国际会议·2013(The 4th International Symposium in Qu 年份:2013
Objective:In vitro information on dextromethorphan (DXM) and the Advanced Dissolution Absorption Metabolism (ADAM) model, incorporated into PBPK simulator Simcyp(@) (v.12) were used to investigate dif...
[会议论文] 作者:Arnim Kraatz,Uwe Lang,Stefan Plass,Matthias Alexander Roth,Pei Hu, 来源:材料与过程促进会SAMPE中国年会 年份:2011
One focus of automotive industry is to reduce the weight of cars especially for electric vehicles (EV). ROHACELL?composite structures offer a significant weight...
[会议论文] 作者:Yan Li,Shan Kang,Pei Hu,RongMiao Zhou,Na Wang,HaiYan Sun, 来源:第十三次全国妇科肿瘤学术会议 年份:2012
[会议论文] 作者:Sheng Feng,Yumi Fukushima,Pei Hu,Conni Weber,Yongqing Wang,Jun Shi, 来源:第四届定量药理学与新药评价国际会议·2013(The 4th International Symposium in Qu 年份:2013
Background and Rationale: Physiologically-based pharmacokinetics (PBPK) modelling is a key component of model-based drug development and is increasingly embraced within the industry and regulatory aut...
[会议论文] 作者:Zhenlei Wang,Qian Zhao,Dongyang Liu,Yupeng Ren,Ji Jiang,Pei Hu, 来源:第五届定量药理学与新药评价国际会议 年份:2015
Background: The prevalence of diabetes mellitus (DM) dramatically increased over the past decades.Dipeptidyl peptidase Ⅳ (DPP-4) inhibitors are a relatively new group of anti-diabetic agents.CPRC3 is...
[期刊论文] 作者:Zhengpei Miao,Pei Hu,Chuanye Nie,Huan Xie,Wenli Fu,Qing Li, 来源:能源化学 年份:2019
Electrochemical reduction of CO2 to produce value-added feedstock chemicals using high-performance electrocatalysts is a promising protocol to address the excessive CO2 in the atmosphere and the energy crisis.However,the high overpotential,......
[期刊论文] 作者:Sheng FENG,Ji JIANG,Pei HU,Jian-yan ZHANG,Tao LIU,Qian ZHAO,Bi-lu LI, 来源:中国药理学报(英文版) 年份:2012
[会议论文] 作者:Yingxiang Wang,Don Zhang,Li Zhang,Pei Hu,Dongyang Liu,Ji Jiang,Fenlai Tan, 来源:2009年亚太地区肿瘤生物学和医学学术会议暨第四届中国中青年肿瘤专家论坛 年份:2009
[会议论文] 作者:pei hu,yan li,na wang,Yu Cao,rongmiao zhou,bingli qi,shan kang, 来源:第十三次全国妇科肿瘤学术会议 年份:2012
[期刊论文] 作者:Pei Hu,Guang-Mei Zheng,Zheng-Sen Dong,Rui Xue,Hong-Cheng Ding,De-Jiao Sun,Bin Xiao, 来源:海南医科大学学报(英文版) 年份:2021
Objective: To use high-frequency ultrasound to evaluate the efficacy of α-lipoic acid combined with traditional Chinese medicine in the treatment of diabetic p...
[会议论文] 作者:Wen Zhong,Xia Chen,Qian Zhao,Ji Jiang,Tao Liu,Hong-zhong Liu,Pei Hu, 来源:第四届定量药理学与新药评价国际会议·2013(The 4th International Symposium in Qu 年份:2013
  Background: Dermatopharmacokinetic (DPK) bioequivalence (BE) evaluation required assessments of stratum corneum (SC) drug content.The SC samples are normall...
[会议论文] 作者:Dongyang Liu,Ji Jiang,Fenlai Tan,Yingxiang Wang,Don Zhang,Li Zhang,Pei Hu, 来源:2009年亚太地区肿瘤生物学和医学学术会议暨第四届中国中青年肿瘤专家论坛 年份:2009
[会议论文] 作者:Tao Liu,Ji Jiang,Xin Zheng,Qian Zhao,Xia Zhao,Yimin Cui,Pei Hu, 来源:第四届定量药理学与新药评价国际会议·2013(The 4th International Symposium in Qu 年份:2013
Aim:Rivaroxaban (Bayer Healthcare AG, Wuppertal, Germany), an oral, direct factor Xa (FXa) inhibitor for the prevention and treatment of thromboembolic disorders has been approved for nonvalvular atri...
[会议论文] 作者:pei hu,yan li,na wang,Yu Cao,rongmiao zhou,bingli qi,shan kang, 来源:第十三次全国妇科肿瘤学术会议 年份:2012
Background The excision repair cross-complementation group 1(ERCC1) gene is the essential member of nucleotide excision repair(NER) pathway,and plays a core role in the response to platinumbased chemo...
[期刊论文] 作者:Yuan Hongwen,Wang Pei,Hu Nijuan,Zhang Peng,Li Chunhua,Liu Yuqi,Ma Liangxiao,Zhu Jiang, 来源:中医杂志(英文版) 年份:2018
De Qi refers to a series of sensations experienced when acupuncture is performed at acupoints.De Qi comprises needling sensations felt by the patient,and the se...
[会议论文] 作者:Jun Shi,Sheng Feng,Meret Martin-Facklam,Cornelia Weber,Richard Peck,Neil Parrott,Pei Hu,Tomohisa Saito, 来源:第五届定量药理学与新药评价国际会议 年份:2015
[会议论文] 作者:Wen Zhong,Hong-Zhong Liu,Xin Zheng,Dong-Yang Liu,Jia Chen,Pei Hu,Jun Shi,Ji Jiang, 来源:第四届定量药理学与新药评价国际会议·2013(The 4th International Symposium in Qu 年份:2013
Background: The distribution of renal function and its effect on drug elimination was not well understood in Chinese population, which impeded the clinical therapeutics for Chinese patients as well as...
[会议论文] 作者:Sheng Feng,Jun Shi,Neil Parrott,Pei Hu,Cornelia Weber,Meret Martin-Facklam,Tomohisa Saito,Richard Peck, 来源:第五届定量药理学与新药评价国际会议 年份:2015
Background and objectives: Bitopertin (RG1678, RO4917838) is a glycine reuptake inhibitor that is postulated to improve NMDA receptor hypofunction by increasing the synaptic concentration of glycine,...
[会议论文] 作者:Pei Hu,Jianzhong Shengtu,Dongyang Liu,Fenlai Tan,Yingxiang Wang,Don Zhang,Li Zhang,Qiong Zhao,Ji Jiang, 来源:2009年亚太地区肿瘤生物学和医学学术会议暨第四届中国中青年肿瘤专家论坛 年份:2009
相关搜索: